- Home
- AAM vs SRDX Comparison
AAM vs SRDX Comparison
Compare AAM & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAM
- SRDX
- Stock Information
- Founded
- AAM 2024
- SRDX 1979
- Country
- AAM United States
- SRDX United States
- Employees
- AAM N/A
- SRDX N/A
- Industry
- AAM
- SRDX Medical/Dental Instruments
- Sector
- AAM
- SRDX Health Care
- Exchange
- AAM Nasdaq
- SRDX Nasdaq
- Market Cap
- AAM 460.0M
- SRDX 416.3M
- IPO Year
- AAM 2024
- SRDX 1998
- Fundamental
- Price
- AAM $10.54
- SRDX $28.76
- Analyst Decision
- AAM
- SRDX Buy
- Analyst Count
- AAM 0
- SRDX 3
- Target Price
- AAM N/A
- SRDX $43.00
- AVG Volume (30 Days)
- AAM 5.9K
- SRDX 133.4K
- Earning Date
- AAM 01-01-0001
- SRDX 11-05-2025
- Dividend Yield
- AAM N/A
- SRDX N/A
- EPS Growth
- AAM N/A
- SRDX N/A
- EPS
- AAM 0.32
- SRDX N/A
- Revenue
- AAM N/A
- SRDX $120,801,000.00
- Revenue This Year
- AAM N/A
- SRDX N/A
- Revenue Next Year
- AAM N/A
- SRDX $3.38
- P/E Ratio
- AAM $32.66
- SRDX N/A
- Revenue Growth
- AAM N/A
- SRDX N/A
- 52 Week Low
- AAM $10.01
- SRDX $26.00
- 52 Week High
- AAM $10.79
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- AAM 60.77
- SRDX 26.82
- Support Level
- AAM $10.50
- SRDX $28.52
- Resistance Level
- AAM $10.54
- SRDX $29.00
- Average True Range (ATR)
- AAM 0.01
- SRDX 0.66
- MACD
- AAM 0.00
- SRDX -0.09
- Stochastic Oscillator
- AAM 100.00
- SRDX 5.71
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.